Leuven, Belgium – 2nd February, 2009 – ThromboGenics NV (Euronext Brussels: THR), a biotechnology company focused on innovative treatments for eye disease, vascular disease and cancer, today announces its Financial Calendar for 2009.
ThromboGenics intends to issue the following financial releases for the 2009 period, on the dates set out below. Please note that all releases will be made after closing of the market.
DATE SUBJECT
Thursday 12th March, 2009 Full Year Results 2008
Tuesday 5th May, 2009 General Shareholders Meeting 2009
Thursday 14th May 2009 Business Update H1
Thursday 27th August 2009 Half Year Results 2009
Thursday 4th November 2009 Business Update H2
